论文部分内容阅读
据美国制药工业协会召开的第四届“开发中的美国老人用新药”会议报道,当前正在开发的老人用新药中,抗癌药物比其它类药物多,总计达124个,其中31个药物正在进行Ⅲ期临床试验。近年来,美国49家从事研究的制药公司和国立癌症研究所正在开发17种治疗癌症及其相关病症的药物。生物技术在癌症治疗药物的研究开发中继续发挥重要作用,正在开发的抗癌药物中
According to the fourth meeting of the Pharmaceutical Industry Association of America on Development of New Drugs for the Elderly, there are more anti-cancer drugs than any other drug currently under development in the elderly, with a total of 124 anti-cancer drugs, of which 31 are in the process of being used Phase Ⅲ clinical trials. In recent years, 49 U.S. pharmaceutical companies and the National Cancer Institute are developing 17 drugs to treat cancer and its related illnesses. Biotechnology continues to play an important role in the research and development of cancer therapeutic drugs, and is under development in cancer drugs